Item 5.07 Submission of Matters to a Vote of Security Holders

The Annual Meeting of Stockholders (the "Annual Meeting") of Microbot Medical Inc. (the "Company") was held on September 21, 2022. At the Annual Meeting, the Company's stockholders voted on the following two proposals and cast their votes as described below. The proposals are described in more detail in the Company's Definitive Proxy Statement on Schedule 14A filed with the U.S. Securities and Exchange Commission on August 8, 2022 (the "Proxy Statement").

Proposal 1: Election of the three nominees listed below to serve as Class I


            Directors on the Board of Directors of the Company until the 2025
            Annual Meeting of Shareholders and until their respective successors
            have been duly elected and qualified:




                 Number of Votes       Number of Votes        Broker
    Name          Cast in Favor           Withheld           Non-Votes
Harel Gadot             2,063,588                32,955       1,462,234
Martin Madden           1,798,187               298,356       1,462,234
Tal Wenderow            2,050,959                45,584       1,462,234

Proposal 2: The ratification of Brightman Almagor Zohar & Co., a Member of


            Deloitte Touche Tohmatsu Limited, or its U.S. affiliate, as the
            Company's independent registered public accounting firm for the year
            ending December 31, 2022:




 Number of Votes       Number of Votes       Number of Votes
  Cast in Favor         Cast Against            Abstained         Broker Non-Votes
        3,467,249                30,840                60,688                     0

Item 9.01 Financial Statements and Exhibits





Exhibit   Description
104       Cover Page Interactive Data File (embedded within the Inline XBRL
          document)

© Edgar Online, source Glimpses